SI-BONE

Company

Last mentioned: Mar 2, 2026

Stories mentioning SI-BONE 2

pharma Neutral

Smith & Nephew Sets Ambitious 2028 Targets Following Q4 Results

Smith & Nephew (SNN) has reported its fourth-quarter results and provided a multi-year financial outlook through 2028, signaling a pivot toward sustained growth. The company is leveraging strategic partnerships, including a collaboration with SI-BONE, to expand its footprint in high-growth medtech segments.

2 sources
medical-devices Neutral

Smith & Nephew Unveils Long-Term Growth Targets Amid Q4 Earnings Momentum

Smith & Nephew has introduced ambitious financial targets for FY26 and FY28, signaling a definitive shift from its operational recovery phase to a sustained growth trajectory. The company’s Q4 results underscore the resilience of its Orthopaedics and Sports Medicine segments, supported by the continued rollout of the CORI robotics platform.

2 sources